Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |